# Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer

> **NCT05945875** · PHASE1 · RECRUITING · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 40 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma
- Recurrent Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** Panitumumab-IRDye800
- **OTHER:** Indium In 111 Panitumumab
- **PROCEDURE:** Single Photon Emission Computed Tomography
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Resection
- **PROCEDURE:** Fluorescence Imaging

## Key facts

- **NCT ID:** NCT05945875
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-03
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05945875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05945875, "Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05945875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*